(RTTNews) – Friday, AbbVie Inc. (ABBV) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of MAVIRET for the treatment of acute hepatitis C infection in adults and children aged 3